亚洲免费av电影一区二区三区,日韩爱爱视频,51精品视频一区二区三区,91视频爱爱,日韩欧美在线播放视频,中文字幕少妇AV,亚洲电影中文字幕,久久久久亚洲av成人网址,久久综合视频网站,国产在线不卡免费播放

        ?

        Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

        2021-01-07 23:21:09EdwardWalshetal
        四川生理科學(xué)雜志 2021年1期

        Edward E Walsh, et al.

        Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease,coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide.Multiple vaccine candidates are under development, but no vaccine is currently available.Interim safety and immunogenicity data about the vaccine candidate BNT162b1 in younger adults have been reported previously from trials in Germany and the United States.

        Methods: In an ongoing, placebo-controlled, observer-blinded, dose-escalation, phase 1 trial conducted in the United States,we randomly assigned healthy adults 18 to 55 years of age and those 65 to 85 years of age to receive either placebo or one of two lipid nanoparticle-formulated, nucleoside-modified RNA vaccine candidates: BNT162b1, which encodes a secreted trimerized SARS-CoV-2 receptor-binding domain; or BNT162b2, which encodes a membrane-anchored SARS-CoV-2 full-length spike, stabilized in the prefusion conformation.The primary outcome was safety (e.g., local and systemic reactions and adverse events); immunogenicity was a secondary outcome.Trial groups were defined according to vaccine candidate, age of the participants, and vaccine dose level (10 μg, 20 μg, 30 μg, and 100 μg).In all groups but one, participants received two doses, with a 21-day interval between doses; in one group (100 μg of BNT162b1), participants received one dose.

        Results: A total of 195 participants underwent randomization.In each of 13 groups of 15 participants, 12 participants received vaccine and 3 received placebo.BNT162b2 was associated with a lower incidence and severity of systemic reactions than BNT162b1, particularly in older adults.In both younger and older adults, the two vaccine candidates elicited similar dose-dependent SARS-CoV-2-neutralizing geometric mean titers, which were similar to or higher than the geometric mean titer of a panel of SARS-CoV-2 convalescent serum samples.

        Conclusions: The safety and immunogenicity data from this U.S.phase 1 trial of two vaccine candidates in younger and older adults, added to earlier interim safety and immunogenicity data regarding BNT162b1 in younger adults from trials in Germany and the United States, support the selection of BNT162b2 for advancement to a pivotal phase 2-3 safety and efficacy evaluation.(Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).

        女的把腿张开男的猛戳出浆| 国产综合精品| 欧美大屁股xxxxhd黑色| 99久久人妻无码精品系列蜜桃 | 亚洲欧美成人一区二区在线电影| 免费av在线国模| 国产一区二区三区涩涩| 国产黄污网站在线观看| 日本乱偷人妻中文字幕在线| 人妻在线中文字幕| 精品国产三级国产av| 国内自拍情侣露脸高清在线| 50岁熟妇大白屁股真爽| 亚洲色欲大片AAA无码| av网站韩日在线观看免费| 无套内射在线无码播放| 无码人妻黑人中文字幕| 国产精品久久久久免费a∨不卡| 久久精品国产在热亚洲不卡| 免费无码精品黄av电影| 日日摸夜夜添狠狠添欧美| 少妇av免费在线播放| 邻居人妻的肉欲满足中文字幕| 免费久久人人爽人人爽av| 亚洲天堂免费视频| 中文字幕人成乱码中文| 体验区试看120秒啪啪免费| 无码精品a∨在线观看十八禁 | 日韩AV无码一区二区三| 亚洲国产精品成人一区二区三区 | 国产av无码专区亚洲av中文| 精品视频入口| 精品国产精品久久一区免费| 麻豆国产精品va在线观看不卡| 88国产精品视频一区二区三区| 无码视频一区=区| 亚洲国产精品久久又爽av| 国产亚洲精品久久777777 | 成人黄网站免费永久在线观看 | 三个男吃我奶头一边一个视频| 少妇厨房愉情理伦片bd在线观看|